Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.

Inside a diseased cell, the genes are in chaos. Some are receiving signals to overproduce a protein. Others are reducing ...

Researchers led by Mass General Brigham report that older adults who took a daily multivitamin for two years showed signs of ...

Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson's disease. While ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

The vote sets in motion the process of rebranding TMH as FSU Health. The agreement includes an FSU investment of $1.7 billion ...

GOTHENBURG, SE / ACCESS Newswire / March 17, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announced that i ...

Roche's rollout of thousands of Nvidia chips is the latest example of a pharmaceutical giant trying to use AI to discover and ...

Clinical research has always been the backbone of medical progress, providing the data and insights needed to develop new ...

Raleigh, NC - March 16, 2026 - PRESSADVANTAGE - Porter Ophthalmology has opened a dedicated Office-Based Surgery suite ...

Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson's disease. While ...